UDK: 615.224

A COMPARATIVE ASSESSMENT OF THE EFFECTIVE THERAPY WITH THE PREPARATION CONTAINING ANTIBODIES TO C-END FRAGMENT OF AT1-RECEPTOR OF ANGIOTENSIN II (CARDOSTAN) AND VALSARTAN (DIOVAN)

E. V. Frolova

Кафедра клинической фармакологии и интенсивной терапии ВолГМУ

Abstract

At present the problem of investigation of new ways in treatment of arterial hypertension in combination with metabolic syndrome and search for remedies able to influence on different symptoms of these diseases simultaneously is of great importance. Cardostan regulates rennin-angiotensin-aldosteron system activity decreasing blood pressure, normalizes lipid profile. It isn’t inferior in hypotensive effect evidence to diovan treatment in dose of 80 mg a day singly. In addition the influence of diovan on lipid metabolism wasn’t revealed.

Keywords

arterial hypertension, treatment, antibodies to C-end fragment of AT-1 receptor of angiotensin II, cardostan, valsartan, diovan

Contacts

Фролова Екатерина Викторовна — заместитель главного врача по медицинской части клиники семейной медицины ВолГМУ, e-mail: e.v.frolova@mail.ru.